Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCalifornia Pacific Medical Center Research Institute

About this trial

To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.

Eligibility criteria

Qualifiers

Patients age >18 years that have been referred for endoscopic treatment of GI lesions.

Disqualifiers

Patients for whom endoscopic treatment was not performed.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

8,000 Participants
are grouped into 3 trial groups